Adidas M/P German soccer jersey, made by Adidas, is a non-seller
Banca Gen M/P May total net inflows Eu433m (April Eu429m)
Burckhardt -3% FY15 results ~3% miss across the board
Daimler M/P Trucks CMD, expect to see more headlines throughout the day
Esure M/P Strategic review of Gocompare all inline
Fresenius M/P Smiths/Fres said to be final bidders for Pfizer's pump unit
Gamesa R Secured a new order from Elecnor
Meyer Burger +1% Awarded contract for over Chf10m
Miners -1% Copper -1%, Brent -0.20%, Iron Ore -0.80%, China +0.01%
Novartis M/P Says Tafinlar Combo Has Better Melanoma Survival Rate.
Royal Dutch -1-2% Investor day, asset sales as planned, Capex higher
Schindler M/P To Buy 25% in China’s Volkslift Elevator, Sets Up JV
Smiths group -1-2% Smiths/Fres said to be final bidders for Pfizer's pump unit
UK
* ESURE-Annouces Strategic review of Gocompare, incl pot. demerger..........+1%
* GOOCH&HOUSEGO-H1.#'s 3% ahead after strong Q2.No chg to FY fcast.........unch
* NETSCIENTIFIC-Further £500k investment in PDS Biotech....................unch
* RETAILERS-read to MKS,NXT,ABF from New Look 'UK Challenging' cmmnts.......-1%
* ROYAL DUTCH- +ive comments re:- synergies,cap ex ahead of todays CMD....+1/2%
* RWS-H1.Strong trading aided by favourable cncy movements................+3-4%
* TULLETT/ICAP deal faces in-depth CMA probe. Deal May Lessen Competition...-1%
Euro
* ACCOR-Hollande wants diversified s/holders (response to Jin Jiang stake)...-1%
* AKER SOLUTIONS-cost cuts on track,NOK400m contract,good visibility.........+1%
* DAIMLER-trucks unit to lay off 1200 workers in US..........................-1%
* DTEL-T-Mobile to give away free shares to customers, stock traded -1.3%....-1%
* FRESENIUS SE-said one of 2 final bidders for $1.5bn PFE pump unit(Rtrs)..+0.5%
* ROYAL DUTCH-Cap Mkt Day-raises BG deal synergies to $4.5bn from $3.5bn.....+1%
* SCHINDLER-buys 25% in Chinese jv partner,option over rest, no financials...U/C
* TELIA-sales of $1bn-valued Fintur unit slowed by worries over US fines.....-1%
Other news
* Investor/Capital Mkt Days: AKER SOLUTIONS, ROYAL DUTCH, HENKEL(day 2)
* US Co's reporting later: Navistar, Valeant
*L'OREAL-Signs accord with Global Bioenergies - Le Figaro.........U/C
*DAIMLER-Trucks to cut 1,240 jobs,WSJ talked about this 15/2.......+0.25%
*SCHINDLER-To buy 25% in Volkslift(China) & sets up JV.............+1%
*FRESENIUS-And Smiths final bidders for PFE Pump Unit,($1.5bln)....U/C
*GAMESA-To install 7 Wind Turbines for Elecnor in Jordan...........+0.5%
*TELIA-Fintur sale has slowed due 2 concerns over past dealings....-0.5%
*ORANGE-To compete with Western Union in Africa Transfers-Echos....+0.5%
*AIR FRANCE-Pilots Union to meet with management June 7th - APF....U/C
*SAP-Uunit pays $59m to settle lawsuit vs California controller....U/C
* BURCKHARDT-Orders 523.2m(516),Sales 487.2m(506),Ebit 73m(76)......-5%
*NOVARTIS-Tafinlar combo has better melanoma survival rate.........+0.25%
*ZODIAC-Utd Tech looking at acq's in interiors,structures(N/D).....+1%
*ACCOR-Hollande wants Accor holders to remain diversfied-AFP.......-1%
After Hours Summary: Z +10% following settlement agreement with NWSA; DRYS -38% after providing details on its liquidityAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: UNFI +10.8%, GIGA +5.4%, XTLY +2.4%
Companies trading higher in after hours in reaction to news: SRPT +26.5% (discloses FDA request that Co provide dystrophin data from biopsies already obtained from the ongoing confirmatory study of eteplirsen), WGBS +12.4% (enters into an exclusive distribution agreement in Japan with Takara Bio), Z +9.5% (settlement agreement with News Corp (NWSA))
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: ENVA -10.6%, PEB -4%, SIGM -3.1%, CASY -2.2%
Companies trading lower in after hours in reaction to news: DRYS -37.7% (After filing 8k which covered previously released Q1 results and updated details regarding liquidity), MSTX -12.6% delays the anticipated timing for announcement of top-line data from its Phase 3 clinical study of vepoloxamer in patients with sickle cell disease), ALXN -11% (announces topline results from Phase 3 REGAIN Study of Eculizumab in patients with refractory generalized myasthenia gravis - REGAIN study missed its primary endpoint), ENVA -10.6% (announces the completion of a prelim assessment of the proposed rule regarding small-dollar loans issued on June 2nd by the CFPB, estimates rev decline of 30-40% if proposed ruling is adopted), ESI -6.4% (ordered by the Department of Education to enhance its finances, according to the WSJ), TRU -2.1% (commences ~15.6 mln common stock offering )